| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |